11th Annual HealthTech Investment Forum

FOCUSING ON DIGITAL HEALTH, MEDTECH & DEVICES

24th of September 2024|MÖVENPICK HOTEL | BASEL | SWITZERLAND

Event Supporters:

Berlin Partner for Business and Technology GmbH

Business and technology support for companies, investors and scientific institutions in Berlin – this is the Berlin Partner für Wirtschaft und Technologie GmbH mission. With customized services and an excellent science and research network, our many experts provide an outstanding range of programs to help companies launch, innovate, expand and secure their economic future in Berlin.

Bio Deutschland e.V.

BIO Deutschland is the sector association of the German biotechnology industry and has set itself the objective of supporting and promoting the development of an innovative economic sector based on modern biosciences. The Berlin-based association currently has over 360 members. It is run by a board of ten members consisting of CEOs and managing directors of biotechnology companies and their investors. Using a wide range of political initiatives, BIO Deutschland lobbies for improvements to the legal parameters for innovative small and medium-sized enterprises. BIO Deutschland represents Germany’s biotechnology sector at the Federation of German Industries (BDI), at the European association (EuropaBio) in Brussels and at the US-American BIO in Washington. The association is also very active in a broad range of events with the aim of providing biotechnology with a platform for discussion and interaction.

BioIndustry Association (BIA)

The BioIndustry Association (BIA) is the trade association for innovative life sciences and biotech industry in the UK, counting over 460 companies including start-ups, biotechnology, universities, research centres, investors, and lawyers among its members. Our mission is to be the voice of the industry, enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation.

BioPartner UK

BioPartner is an independent, government-accredited trade organisation, promoting international partnering for trade, investment and collaborations with UK Life Science companies. BioPartner's delegations promote the UK presence at major international biopharma conferences, and companies are assisted with access to government grants and heavily discounted entry fees. Through the BioPartner Programme, members receive extra benefits and support to effectively trade overseas.

Biopôle SA

Based in Lausanne, Biopôle is one of the largest life sciences campuses in Europe. It supports emerging enterprises via its collaborative ecosystem. Pioneering spaces like StartLab, Superlab and the Digital Health Hub encourage people to connect, and its Start-up Fund and Vanguard Accelerator offer financial and strategic support. The vibrant community includes 150 companies, 25 academic research groups and 2,500 people, developing cutting-edge innovations in pharma, biotech and digital health.

Biotechgate

Biotechgate is the global Business Development Database for the Biotech, Pharma and Medtech industries.

Over 900,000 clinical trials

60,000 company database

Over 40,000 Biotech, Pharma and Medtech assets available for licensing

Over 350,000 management contact details

The latest M&A Deals Product pipelines

In depth market research reports

Dedicated investor database

Edison Group

Edison Group is an international advisory firm with around 450 corporate clients and 110 people working from offices in London, New York, Frankfurt, Sydney and Wellington. The team consists of 80 analysts, investment and logistics professionals with experience in capital markets, investor roadshows and communications. Healthcare is Edison’s largest sector, with 16 analysts covering over 100 biotech and medtech stocks across the UK, continental Europe, North America and Asia-Pacific.

EIT Health Germany-Switzerland

EIT Health Germany-Switzerland is one of a total of seven Co-Location Centres (CLCs) and Innostars in Europe. It is currently serving more than a dozen leading companies and public health care institutions in Germany and Switzerland, as well as renowned universities and research institutions, to realise EIT Health’s mission of a public-private partnership. The aim is to jointly address the urgent health challenges of our time with concrete measures and programmes to open up new resources for established and young companies – and to realize their ideas in common products and services for the European market.

European Healthcare Investor Association

European Healthcare Investor Association is the largest association of private capital providers investing in healthcare companies in Europe. Our aim is to provide networking and training opportunities to our members, to deliver sector focussed market data and analysis and to promote a better understanding of investors’ contribution to the healthcare economy. The Association has grown rapidly to over 60 members including private equity, infrastructure and sovereign funds, foundations and family office investors, senior managers, advisors and other members of the healthcare investing community, all focussed on building successful healthcare businesses. E.H.I.A. works in partnership with strategic partners in the advisory community including McKinsey & Company (strategy consulting), J P Morgan (investment banking), McDermott Will & Emery (legal), Compass Carter Osborne (executive search), Marwood Group (regulatory consulting), Knight Frank (real estate), RSM Ebner Stolz (accounting), and Marsh (insurance). Investors in Healthcare (www.investorsinhealthcare.com), the Official Journal of the Association, is a Google News approved, digital resource delivering healthcare investor focussed news, data and analysis. Access to the journal is complementary to our members, with subscriptions available for non-members.

FreeMind Group

FreeMind is a consulting group whose goal is to assist in maximizing potential to receive funding from non-dilutive sources. Established in 1999, FreeMind is the largest consulting group of its kind working with academics and Industry alike. FreeMind's proven long-term strategic approach has garnered its clients over 1.5 billion dollars to date.

Our expertise in applying for grants and contracts extends throughout every government mechanism open to funding the life sciences including all NIH institutes, DoD, NSF, FDA, CDC, BARDA, etc., as well as private foundations.

FreeMind's knowledgeable and experienced team of Client Strategists and Project Managers are dedicated to guiding non-dilutive funding efforts from identification of the most suitable opportunity through to submission and subsequent award. Our team of experts will assist in making non-dilutive funding a key tool in a long-term financial strategy.

Instinctif Partners

Instinctif Partners is an international business communications consultancy. With a track record of delivering truly creative programmes, the Life Sciences practice focuses on enhancing the value proposition for companies seeking investment, partnerships or customers. Our core skill is working with clients to communicate the value of their science and innovation to key stakeholders through the most relevant channels: crafting communications solutions that showcase each company, product or technology. Specifically, we are unique in offering specialist expertise seamlessly across corporate, financial, healthcare and marketing communications with outreach programmes to media, industry, professional, public, financial and investment communities. Our service offering covers all communications disciplines including strategic counsel, PR, IR, media relations, public affairs, crisis communications, internal communications, marketing, advertising, copywriting, design, research and event management. Our globally integrated and dedicated life sciences team serves clients around the world from our headquarters in London, and bases across Europe, AsiaPac and the USA.

Instinctif Partners

Lyonbiopôle

As a French biocluster, Lyonbiopole Auvergne-Rhône-Alpes is the gateway to healthcare innovation in Auvergne-Rhône-Alpes, France. It aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges.

MedEdge MEA

MedEdge MEA is a bi-monthly magazine by Two Point Five Media LLC, that focuses on providing evidence-based health information and expert advice on various topics such as nutrition, fitness, mental well-being, disease prevention, and healthy lifestyle choices. Also, covers in-depth articles, interviews with healthcare professionals, success stories, and practical tips for readers. With each bi-monthly issue, we strive to deliver insightful articles, practical advice, and comprehensive guidance to help you simplify life, amplify happiness, nurture family bonds, and make informed decisions in the realm of beauty and luxury. Our extensive coverage across the Middle East and Africa makes us the ideal choice for a diverse readership. Whether you reside in Dubai or Durban, Riyadh or Rabat, Doha or Dar es Salaam, Muscat or Mombasa, MedEdge Magazine is here to serve you. Our readership includes families, healthcare professionals, fitness enthusiasts, nutritionists, trendsetters, and many more. At MedEdge, we have established ourselves as a dynamic, popular, youthful, and savvy publication. The expressions of gratitude and kind words from our readers are the fuel that ignites our passion, reinforcing the positive influence we have had on their lives, and driving us to continue producing meaningful content.

MEDiSTRAVA

MEDiSTRAVA Consulting is a new strategic communications and healthcare advisory group created to fast-track our biotech and pharma clients to success. We channel global expertise across corporate communications, investor relations, medical and regulatory affairs, HEOR and market access to enable clients to achieve their full potential.

MedNous

MedNous is a print publication and a website for everyone involved in medical research in Europe. The name is derived from the Greek word for knowledge – nous – and the English word, medical.

The print publication analyses complex issues that life science professionals need to understand in order to bring their research into commercial development. These issues relate to regulatory affairs, patent law, government research policy and funding. The print publication appears 10 times per year and includes news, company interviews and commentary by corporate executives and other practicioners in this field.

Optimum Strategic Communications

Optimum Strategic Communications is an international healthcare communications firm which specialises in strategic investor relations, corporate and financial communications. Our senior team of healthcare specialists, based in London, Amsterdam, Stockholm, Zurich, and New York, are experienced and trusted advisors to some of the world's most exciting public and private companies, both large and small, across pharmaceuticals, medtech, biotech, health tech and healthcare services. Over the last 25 years, our team has worked with over 300 healthcare companies, advising them on financial communications and investor relations, including major corporate activity such as fundraising, IPOs, M&A, as well as corporate reputation and crisis scenarios. We have an exceptional network of contacts across the international investment community in Europe and the US; contacts we have built and maintained over the last three decades. The Optimum team includes ex-fund managers and analysts, as well as financial and corporate communications specialists.

Optimum Strategic Communications

Plattform Life Sciences

The Life Sciences-Series - Launched in 2014 four issues of the Life Sciences-Series appear annually. Based on the three pillars – technology, financing, investment – the issues combine current topics of life sciences with knowledge and networking from corporate financing and capital market. The mission: Building a cross medial bridge between the life sciences and the financial industry by the help of the quarterly Life Sciences issues, the monthly digital newsletter LifeSciencesUpdate.

Secarna Pharmaceuticals GmbH & Co. KG

Redefining the discovery and development of best-in-class oligonucleotide therapeutics Global collaborations on antisense oligonucleotides from discovery to Phase 2 Lead proprietary immune-oncology program with very strong translational preclinical package, ready to enter IND enabling CMC & tox studies. 2nd runner (Co-Development) program within rare disease space, offering accelerated path to clinical PoC within 3 years. 18 fully dedicated scientists / employees / management folks to get next-level products to patients www.secarna.com

Secarna Pharmaceuticals GmbH & Co. KG

Swiss Biotech Association

Swiss Biotech unites the four leading biotech regions of Switzerland (BioAlps, BaselArea, Biopolo Ticino and Greater Zurich Area). The regions have early on combined efforts with the SWX Swiss Exchange which holds a leading position in terms of life-science listings and services.

The National Industry Association named Swiss Biotech Association Represents more than 150 companies to date and acts as the operational arm for the marketing alliance. Swiss Biotech raises Switzerland’s profile as an economic center in Europe and profiles the biotech industry with its key research institutions and companies. Swiss Biotechs’ mission is to spread the message of Switzerland as one of the top biotech locations in the world. This will be achieved by presenting a comprehensive picture of the drivers of biotechnology including research, education, economics, finance and industry. The bases for success in biotechnology are the critical mass of research institutes and accelerated technology transfer. The early integration of industry and well-trained workforce is another critical success factor for rapid economic growth. More than 40 technology parks throughout the country support the increasingly important and successful TechTransfer process.

Tiberend Strategic Advisors, Inc.

Tiberend Strategic Advisors, Inc. is a corporate communications firm providing media strategy and execution for life science companies – biotech (therapeutics), medical devices and diagnostics. We work with both public and private emerging growth companies:

1. To enhance valuation

2. To build visibility for partnerships and strategic alliances